Slider
DHB-Med 100 product pack
Deus Medical logo

DHB-MED 100 (Dihydroboldenone Cypionate)

• CAS number: 65-06-5
• Molecular Weight: 288.43 g/mol
• Formula: C19H28O2

Authenticity protected scan our product QR code

DHB-MED 100 by DEUS MEDICAL®

DHB-MED 100 (Dihydroboldenone Cypionate)
DHB-Med 100 product pack

Overview

DHB-MED 100 (Dihydroboldenone Cypionate) is an analogue of testosterone. It is useful in hormone replacement therapy, the treatment of breast cancer, osteoporosis and decreased libido. It is manufactured as dihydroboldenone cypionate 100mg/ml injection, containing dihydroboldenone cypionate 100mg and excipients. 

Dihydroboldenone Cypionate Mechanism of Action

Dihydroboldenone cypionate acts on androgen receptors, exhibiting moderate androgenic properties, but high anabolic properties. It can be used in hormonal replacement therapy. It is also used to stimulate muscle growth, development and fat distribution.

Dihydroboldenone Cypionate Dosage

100mg weekly by intramuscular injection, max of 400mg monthly.

Dihydroboldenone Cypionate Side effects

Virilization prostate enlargement, nausea, vomiting, skin colour changes, priapism swelling of feet. 

Composition

✓ Dihydroboldenone Cypionate . . . . . . 100mg
✓ Excipients . . . . . . . . . . . . . . . . . . . . . q.s

Precautions for storage:
Because of the high concentration of the product, it is susceptible to crystallization when exposed to colder temperatures. It’s best to follow the process of re-dissolving the product if this has happened. Crystallization does not impact patient safety, efficacy, or product quality.

DHB-Med 100 back of the product pack
Authenticity protected scan our product QR code

BECOME A PARTNER

We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.